Intelligence in weeks, not months, without trading away rigour
Traditional research timelines were designed for markets that stood still. Yours does not. A competitor repositions, a regulation shifts, a buyer’s priorities change, and the report you commissioned last quarter is already describing a market that no longer exists
We run an AI-accelerated intelligence engine: synthesis tools that compress analysis from months to weeks, sector databases including GlobalData, EvaluatePharma and IHS Markit, primary research platforms, and continuous competitor monitoring, all turned into clear, executive-ready visual outputs
AI accelerates our synthesis; our analysts own every conclusion. Speed without rigour is just faster guessing, we do not do it
Monitoring is continuous, not commissioned. You stop reviewing the market annually and start watching it live
Outputs are built for the boardroom, designed to be presented, challenged and acted on, not filed
Twice failed to enter Japan.
We changed the basis of the decision from assumption to evidence
Refocused on two named accounts, capital protected.
